NCT06121752 2024-10-15
DNET
Asian Institute of Gastroenterology, India
Phase NA Unknown
Clinical Trials
85 trialsNCT06321692 2024-03-20
Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications
European Institute of Oncology
Phase NA Unknown
NCT05475210 2024-03-13
177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors
Molecular Targeting Technologies, Inc.
Phase 1 Unknown
NCT05334290 2024-03-12
FiReNEN
IRCCS San Raffaele
Unknown
NCT06159920 2024-03-06
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.
IRCCS San Raffaele
Unknown
NCT01763554 2024-01-30
Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014
AHS Cancer Control Alberta
Unknown
NCT05709171 2023-11-22
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Rigshospitalet, Denmark
Phase 2 Unknown
NCT05448157 2023-09-22
RGS-GEP-NET
European Institute of Oncology
Unknown
NCT04897542 2023-09-18
Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT05973968 2023-08-04
Surufatinib in G3 Neuroendocrine Tumors
Qilu Hospital of Shandong University
Unknown
NCT04444401 2023-06-28
Registry on NEN Patients and COVID-19
European Institute of Oncology
Unknown
NCT05513469 2023-04-07
Radio-Marker
Erasmus Medical Center
Phase NA Unknown
NCT03475953 2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2 Unknown
NCT04045834 2023-02-14
Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Unknown
NCT02693067 2023-02-08
A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver
Provectus Pharmaceuticals
Phase 1 Unknown
NCT05693519 2023-01-23
GICCA
Leiden University Medical Center
Unknown
NCT05647954 2022-12-13
A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver
Taizhou Hanzhong biomedical co. LTD
Phase 3 Unknown
NCT03478358 2022-08-31
Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
Peking Union Medical College Hospital
Phase 1 Unknown
NCT04525638 2022-08-02
A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours
Fundación de investigación HM
Phase 2 Unknown
NCT02817945 2022-04-07
Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT05268952 2022-03-07
A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)
University Hospital, Antwerp
Phase NA Unknown
NCT05234450 2022-02-10
Camune
University Hospital, Strasbourg, France
Unknown
NCT05113355 2021-11-24
Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm
Peking Union Medical College Hospital
Phase 2 Unknown
NCT05076786 2021-11-03
Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04927611 2021-09-24
Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm
Fudan University
Unknown
NCT04427787 2021-09-05
LOLA
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT04931446 2021-06-18
Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis
Fudan University
Unknown
NCT02823691 2021-06-07
MetNET-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase EARLY_PHASE1 Unknown
NCT04331912 2021-05-13
PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment
University of Warmia and Mazury
Unknown
NCT04790708 2021-03-10
FENET-2016
University Hospital of Ferrara
Phase NA Unknown
NCT01744249 2021-02-02
Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
Grupo Espanol de Tumores Neuroendocrinos
Phase 2/3 Unknown
NCT04017104 2021-01-26
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
British Columbia Cancer Agency
Unknown
NCT04720391 2021-01-22
MONET
European Institute of Oncology
Unknown
NCT04085211 2020-11-30
Image-Enhanced Endoscopy in the Gastrointestinal Tract
King's College Hospital NHS Trust
Unknown
NCT04622631 2020-11-10
Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT
Sheba Medical Center
Unknown
NCT04491851 2020-11-05
Impact of Peptides and Chelators on Somatostatin Receptor Antagonists
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04194125 2020-11-04
Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer
University of Warmia and Mazury
Phase 2 Unknown
NCT04557137 2020-09-21
Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia
University of Aarhus
Unknown
NCT03881306 2020-08-20
DEBOXA for Inoperable NET Liver Metastases
Xiangya Hospital of Central South University
Phase 1/2 Unknown
NCT03734913 2020-07-22
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04207463 2020-06-17
A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Unknown
NCT04336839 2020-04-07
PVNET
Royal Free Hospital NHS Foundation Trust
Unknown
NCT04029428 2020-04-01
POLNETS_PRRT
University of Warmia and Mazury
Phase 2 Unknown
NCT00874614 2020-02-20
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Molecular Insight Pharmaceuticals, Inc.
Phase 2 Unknown
NCT03422029 2020-02-07
Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients
Peking University
Phase 2 Unknown
NCT04198402 2019-12-13
MicroTEND
Assistance Publique - Hôpitaux de Paris
Unknown
NCT04152928 2019-11-06
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT04154241 2019-11-06
Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT04066322 2019-09-24
RMPanNET
Fudan University
Unknown
NCT04041882 2019-08-01
68Ga-DOTATATE PET/CT in Neuroendocrine Tumor
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown